by In2Pharma | Jul 5, 2022 | News
Belgium On 4th of July 2022, the FAMHP launches the Medicinal Product Management database, a new internal database for medicinal products. Due to the launch of the new database, existing databases will temporarily not be updated. As from 22nd June data will be...
by In2Pharma | Feb 25, 2022 | News
Belgium On 03.02.2022, the Federal Parliament approved a law that adjusts the financing of the Federal Agency for Medicines and Health Products (FAMHP). This has been published in the Belgian Official Journal and will come into force soon. The law introduces new taxes...
by In2Pharma | May 5, 2021 | News
Belgium FarmaStatus is the online application that collects information about the availability of medicines in Belgium. The application shows when medicines are temporarily unavailable, when the commercialization was temporarily or permanently stopped and when...
by In2Pharma | Feb 23, 2021 | News
Belgium The FPS Health, Food Chain Safety and Environment, the National Institute for Sickness and Disability Insurance (NIHDI) and the Federal Agency for Medicines and Health Products (FAMHP) will move to a common building on 1 March 2021. This enables an even...
by In2Pharma | Jan 7, 2021 | News
The Netherlands As of 1st January 2021, the Medicines Evaluation Board (MEB) will increase the fees for marketing authorization applications and changes the annual fee for medicines for human use and the fees for consultation procedures. The fees for veterinary...
